(Q35088551)

6 August 2017

1 reference

title

Suppressors of cytokine signalling: SOCS. (English)

1 reference

6 August 2017

Lykke Larsen

1

1 reference

PubMed ID

12645661

6 August 2017

Carsten Röpke

series ordinal

2

1 reference

6 August 2017

1 December 2002

1 reference

Acta Pathologica et Microbiologica Scandinavica

6 August 2017

1 reference

6 August 2017

110

1 reference

6 August 2017

833-844

1 reference

6 August 2017

12

1 reference

Cytokine control of developmental programs in normal hematopoiesis and leukemia

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Jaks and STATs: biological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

The Stat family in cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Cytokine signaling in 2002: new surprises in the Jak/Stat pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Negative regulators of cytokine signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

A new protein containing an SH2 domain that inhibits JAK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Structure and function of a new STAT-induced STAT inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

A family of cytokine-inducible inhibitors of signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Twenty proteins containing a C-terminal SOCS box form five structural classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Cloning and characterization of novel CIS family genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Gigantism in mice lacking suppressor of cytokine signalling-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Interferon-alpha induces transient suppressors of cytokine signalling expression in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Indirect induction of suppressor of cytokine signalling-1 in macrophages stimulated with bacterial lipopolysaccharide: partial role of autocrine/paracrine interferon-alpha/beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

SOCS-3 is an insulin-induced negative regulator of insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Lack of Socs2 expression causes the high-growth phenotype in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

7 January 2021

SOCS3 is essential in the regulation of fetal liver erythropoiesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

7 January 2021

Identification of Critical Residues Required for Suppressor of Cytokine Signaling-specific Regulation of Interleukin-4 Signaling

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

7 January 2021

Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

7 January 2021

CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

7 January 2021

Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

7 January 2021

Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

7 January 2021

Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

7 January 2021

The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

7 January 2021

SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.1101201.X

7 January 2021

10.1034/J.1600-0463.2002.1101201.X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12645661